Next, we investigated the representation of Ecad and NGFR gene signatures in pre- and post-BRAFi/MEKi treated melanoma and observed a significant upregulation of NGFR-core genes such as EHD3 (p = 0.042). The gene discussed is NGFR; the disease is melanoma.